SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-033077
Filing Date
2020-10-23
Accepted
2020-10-23 17:26:37
Documents
2
Period of Report
2020-10-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea128856-8k_cmlifescien.htm 8-K 21460
2 PRESS RELEASE, DATED OCTOBER 23, 2020 ea128856ex99-1_cmlifescien.htm EX-99.1 5033
  Complete submission text file 0001213900-20-033077.txt   27607
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020 212 474 6700
CM Life Sciences, Inc. (Filer) CIK: 0001818331 (see all company filings)

IRS No.: 851966622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39482 | Film No.: 201258573
SIC: 6770 Blank Checks